DISCO Pharmaceuticals
GermanyEntry
2023
Hold
3yr
Status
Active
Who owns DISCO Pharmaceuticals?
DISCO Pharmaceuticals is a German Biotech company, currently owned by NRW.BANK since 2025 and 2 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Most recent investor
Sofinnova PartnersSofinnova Capital X · 2021 · Life Sciences VC
3 ownership periods · full history below
Key facts
HQGermany
SectorBiotech
Ownership history
3 ownership periods · co-invest detected
Active
Co-invest · 3 holders · 2023 · present
Sofinnova PartnersActive
2023 · present(3yr) · Sofinnova Capital X · 2021 · Life Sciences VC
Panakes Partners SGRActive
2024 · present(2yr) · Panakes Fund Purple · 2021 · Life Sciences VC
NRW.BANKActive
2025 · present(1yr) · NRW.Venture · 2006 · VC
More from Sofinnova Capital X
Other portfolio companies in the same fund.
Denmark
France
Spain
UK
USMore PE-backed in Biotech
Comparable biotech deals from other GPs.
Questions
Who owns DISCO Pharmaceuticals?
DISCO Pharmaceuticals is currently owned by NRW.BANK, Panakes Partners SGR and 1 other, through Sofinnova Capital X, since 2025.
When did NRW.BANK and 2 others acquire DISCO Pharmaceuticals?
NRW.BANK and 2 others acquired DISCO Pharmaceuticals in 2025.
Who has owned DISCO Pharmaceuticals over time?
DISCO Pharmaceuticals has been through 3 private-equity ownership periods: Sofinnova Partners · via Sofinnova Capital X · since 2023; Panakes Partners SGR · via Panakes Fund Purple · since 2024; NRW.BANK · via NRW.Venture · since 2025.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue